Detalles de la búsqueda
1.
2D Film-Like Magnetic SERS Tag with Enhanced Capture and Detection Abilities for Immunochromatographic Diagnosis of Multiple Bacteria.
Small
; 20(22): e2310014, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38193262
2.
Atezolizumab plus bevacizumab versus nivolumab as first-line treatment for advanced or unresectable hepatocellular carcinoma: A cost-effectiveness analysis.
Cancer
; 128(22): 3995-4003, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36111952
3.
Population genetic analysis of the Plasmodium falciparum erythrocyte binding antigen-175 (EBA-175) gene in Equatorial Guinea.
Malar J
; 20(1): 374, 2021 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34538247
4.
Genetic diversity and natural selection on the thrombospondin-related adhesive protein (TRAP) gene of Plasmodium falciparum on Bioko Island, Equatorial Guinea and global comparative analysis.
Malar J
; 20(1): 124, 2021 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33653360
5.
Genetic polymorphism of Plasmodium falciparum circumsporozoite protein on Bioko Island, Equatorial Guinea and global comparative analysis.
Malar J
; 19(1): 245, 2020 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32660484
6.
Panax notoginseng preparations as adjuvant therapy for diabetic kidney disease: a systematic review and meta-analysis.
Pharm Biol
; 58(1): 138-145, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31967924
7.
Natural selection and genetic diversity of domain I of Plasmodium falciparum apical membrane antigen-1 on Bioko Island.
Malar J
; 18(1): 317, 2019 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-31533747
8.
Reconstruction of unreported subgroup survival data with PD-L1-low expression in advanced/metastatic triple-negative breast cancer using innovative KMSubtraction workflow.
J Immunother Cancer
; 12(1)2024 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38212119
9.
Nivolumab plus ipilimumab versus the EXTREME regimen in recurrent/metastatic squamous cell carcinoma of the head and neck: a cost-effectiveness analysis.
Sci Rep
; 14(1): 6807, 2024 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38514766
10.
Adverse events associated with immune checkpoint inhibitors in non-small cell lung cancer: a safety analysis of clinical trials and FDA pharmacovigilance system.
Front Immunol
; 15: 1396752, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745663
11.
Cost-effectiveness analysis of durvalumab, tremelimumab, and etoposide-platinum in first-line treatment of extensive-stage small cell lung cancer.
Medicine (Baltimore)
; 103(16): e37836, 2024 Apr 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38640325
12.
Tislelizumab plus chemotherapy is more cost-effective than chemotherapy alone as first-line therapy for advanced non-squamous non-small cell lung cancer.
Front Public Health
; 11: 1009920, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36794070
13.
Cost-effectiveness of trastuzumab deruxtecan for previously treated HER2-low advanced breast cancer.
PLoS One
; 18(8): e0290507, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37616309
14.
Cost-effectiveness of camrelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer.
Immunotherapy
; 15(14): 1133-1142, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37492009
15.
Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with or without PD-L1 selection: A systematic review and network meta-analysis.
Chin Med J (Engl)
; 136(18): 2156-2165, 2023 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37596898
16.
Comparative efficacy and safety of immune checkpoint inhibitors for unresectable advanced melanoma: A systematic review and network meta-analysis.
Int Immunopharmacol
; 115: 109657, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36608446
17.
Cost-effectiveness of cemiplimab plus chemotherapy versus chemotherapy for the treatment of advanced non-small cell lung cancer.
Front Oncol
; 13: 1113374, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37182130
18.
Immune checkpoint inhibitors in first-line therapies of metastatic or early triple-negative breast cancer: a systematic review and network meta-analysis.
Front Endocrinol (Lausanne)
; 14: 1137464, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37229447
19.
Cost-effectiveness analysis of first-line serplulimab combined with chemotherapy for extensive-stage small cell lung cancer.
Front Public Health
; 11: 1156427, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37727602
20.
Cost-effectiveness of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Front Oncol
; 13: 1162360, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37251935